CVRx Q2 revenue up 15% to $13.6M; narrows FY25 guidance; names COO

CVRx, Inc.

2025-Q2 EPS reported -$1.10 vs consensus -$0.53 ▼ miss (-107.4%)

Q2 2025 revenue $13.6M (+15% YoY); U.S. HF revenue $12.1M (+15%); net loss $14.7M ($0.57/share).
Cash and equivalents $95.0M; net cash used in ops/investing $8.0M vs $10.2M prior year.
Full-year 2025 revenue guidance narrowed to $55-57M (from $55-58M); Q3 2025 revenue expected $13.7-14.7M.
CMS proposed keeping Barostim in APC 1580 for 2026 at ~$45,000 payment; Category I CPT codes set for Jan 2026.
Appointed Brent Binkowski as COO effective Aug 11, 2025; base salary $405k, equity awards of 74,900 options and 16,600 RSUs.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.